Merck CFO to Participate in Wells Fargo Healthcare Conference Fireside Chat

Merck announced that Caroline Litchfield and Eliav Barr will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on September 4, 2025. Investors and the public can listen to the live audio webcast at this link. Merck is a research-intensive biopharmaceutical company focused on developing medicines and vaccines to save and improve lives.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has announced that Caroline Litchfield, executive vice president and chief financial officer, and Eliav Barr, senior vice president, head of global clinical development and chief medical officer, Merck Research Laboratories, will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on Thursday, September 4, 2025, at 11:50 a.m. EDT [1]. The event will be accessible via a live audio webcast.

Merck, a research-intensive biopharmaceutical company, is committed to using leading-edge science to save and improve lives worldwide. With a history spanning over 130 years, the company has developed numerous important medicines and vaccines. Merck aims to be the premier research-intensive biopharmaceutical company globally, focusing on innovative health solutions to prevent and treat diseases in people and animals [2].

The fireside chat will provide an opportunity for investors, analysts, and the general public to hear from Litchfield and Barr about Merck's strategic direction, financial performance, and advancements in clinical development. The event is set to offer insights into the company's approach to addressing healthcare challenges and its commitment to fostering a diverse and inclusive global workforce [1].

Merck's participation in the conference comes amid a period of significant risk and uncertainty for the pharmaceutical industry. The company has identified several key risks, including general industry conditions, competition, economic factors, regulatory changes, and technological advancements. These risks are detailed in Merck's forward-looking statements, which are subject to significant uncertainties and potential material differences from actual results [1].

Investors and financial professionals are encouraged to tune in to the live audio webcast to gain a comprehensive understanding of Merck's current position and future prospects. The event will be an excellent opportunity to hear from the company's senior leadership and engage with their insights on the healthcare industry.

References:
[1] https://www.merck.com/news/merck-to-participate-in-the-2025-wells-fargo-healthcare-conference/
[2] https://www.marketscreener.com/news/merck-to-participate-in-the-2025-wells-fargo-healthcare-conference-ce7c50dfde88f72c